Complications and management of penile enhancement procedures
Translational Andrology and Urology · 2025-10 · 14 (10) · 3367-3376
DOI: 10.21037/tau-23-519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Andrology and Urology, 2025-10. Verfasst von Michael Pignanelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Albany Medical College, Albany, NY, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Demand for penile enhancement-driven by cosmetic and psychological goals-is rising, and complications are increasingly encountered in urologic practice. This review offers practical, procedure-focused guidance on diagnosing and managing adverse events after injectable fillers, self-injection of foreign substances, dermal matrices, autologous fat transfer, and the subcutaneous silicone Penuma implant. Hyaluronic acid (HA) is the most commonly used filler and, when applied with standardized, low-volume protocols, generally has lower complication rates than polylactic acid (PLA), polymethylmethacrylate (PMMA), silicone, or nonmedical self-injected materials. Typical HA-related issues include migration, nodules, Tyndall effect, phimosis, and infection; management emphasizes early massage/modeling, warm compresses, judicious hyaluronidase for confirmed HA, antibiotics with drainage for abscess, and selective surgical excision for refractory nodules. Permanent fillers and self-injected substances are associated with granuloma, necrosis, infection, lymphedema, and disfiguring inflammation; these often require wide excision down to Buck's fascia with reconstructive strategies such as split-thickness skin grafts or scrotal/dartos flaps. For dermal matrix and fat transfer, complications include edema, hematoma, infection (commonly Staphylococcus aureus or Escherichia coli), necrosis, contour deformity, and rare fat embolism; treatment ranges from compression and local debridement to staged reconstruction. The Penuma implant presents device-specific problems-seroma, infection, distal flaring with impending erosion, capsular contracture, curvature, and shortening-managed with antibiotics, wound care, traction or vacuum therapy, revision, or explantation with postoperative rehabilitation; salvage in frank infection is not described. Across modalities, prevention hinges on patient selection, informed consent with expectation management, sterile technique, and adherence to standardized injection/implant protocols. Timely recognition of early versus late complications and use of clear algorithms can preserve cosmesis and function. This review distills current data and referral-center experience into actionable steps for clinicians who perform or manage complications of penile enhancement procedures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Albany Medical College, Albany, NY, USA.
- Department of Urology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Zitieren
APA
Pignanelli, M., Williams, J. M., Fernandez Crespo, R. E., Britt, J., Parker, J., & Carrion, R. (2025). Complications and management of penile enhancement procedures. Translational Andrology and Urology, 14(10), 3367-3376. https://doi.org/10.21037/tau-23-519
Vancouver
Pignanelli M, Williams JM, Fernandez Crespo RE, Britt J, Parker J, Carrion R. Complications and management of penile enhancement procedures. Translational Andrology and Urology. 2025;14(10):3367-3376. doi:10.21037/tau-23-519
BibTeX
@article{Pignanelli2025,
author = {Pignanelli, Michael and Williams, J Matt and Fernandez Crespo, Raul E and Britt, Jacob and Parker, Justin and Carrion, Rafael},
title = {Complications and management of penile enhancement procedures},
journal = {Translational Andrology and Urology},
year = {2025},
volume = {14},
number = {10},
pages = {3367--3376},
doi = {10.21037/tau-23-519}
}
EUVIMED